Case report of sigmoid colon cancer with synchronous peritoneal metastasis achieving a pathological complete response after mFOLFOX6 plus cetuximab

一例乙状结肠癌伴同步性腹膜转移患者接受mFOLFOX6联合西妥昔单抗治疗后达到病理完全缓解的病例报告

阅读:1

Abstract

INTRODUCTION: Synchronous peritoneal metastasis occurs in about 5 % of colorectal cancer (CRC) cases, often with other distant metastases. Due to poor drug penetration, chemotherapy is typically ineffective, leading to poor prognosis. Here, we report a rare case of sigmoid colon cancer with synchronous peritoneal metastasis achieving pathological complete response (pCR) after systemic chemotherapy. CASE PRESENTATION: A 74-year-old man was diagnosed with acute generalized peritonitis from a perforated sigmoid colon cancer with two peritoneal metastases. One peritoneal lesion was left unresected, and sigmoid colectomy with partial jejunal resection was performed. Additionally, postoperative colonoscopy revealed a synchronous cancer in the cecum. Chemotherapy with mFOLFOX6 plus cetuximab was initiated. After 10 cycles, the patient developed strangulation ileus, requiring surgery, during which a peritoneal nodule was resected and showed no viable cancer cells, indicating pCR. Chemotherapy was resumed and completed to 12 cycles. Laparoscopic ileocecal resection for the cecal cancer also achieved pCR. A single peritoneal recurrence was surgically removed. No recurrence has been observed for 7 months. DISCUSSION: Reports of pCR with peritoneal metastases are extremely rare. Although the mechanism of the remarkable response in this case remains unclear, given the rarity of pCR in CRC with peritoneal metastasis, further case accumulation and analysis are warranted. CONCLUSION: This is a rare case of pCR to systemic chemotherapy for CRC with synchronous peritoneal metastasis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。